Skip to main content

Two Popular Diabetes Drugs Outperform Two Others in Head-to-Head Comparison

September 21, 2022

Dr. John Buse and colleagues complete first study comparing commonly used medications for type 2 diabetes Diabetes affects more than one out of every ten Americans and about one out of every three people in their lifetime. Type 2 diabetes occurs when the pancreas does not produce enough insulin — a hormone that regulates the … Read more

Drs. Stouffer and Cavender Co-Directing 21st Annual North Carolina Cardiovascular Update, Register Here

September 20, 2022

The live in-person event is an educational opportunity for cardiologists, cardiac surgeons, internists, and other health professionals involved in the treatment of cardiovascular disease. Cases will be reviewed and optimal treatment plans for various cardiovascular diseases will be provided. Drug therapies and new technologies will also be discussed. Dr. Rick Stouffer, chief of the Division … Read more

Drs. Phanstiel and Loeser Receive $2.5M NIH NIAMS Grant to ID Osteoarthritis Risk Genes

September 20, 2022

Dr. Richard F. Loeser is the Joseph P. Archie, Jr. Eminent Professor of Medicine in the Division of Rheumatology, Allergy and Immunology. Dr. Doug Phanstiel – who is in the Department of Cell Biology and Physiology – is the principal investigator, and Dr. Loeser is a co-principal investigator for the National Institute of Arthritis and Musculoskeletal and … Read more

October Holidays and Observances: LGBTQ History, Yom Kippur and Diwali

September 20, 2022

Many historical and religious observances and holidays are celebrated during October. It is a time to educate ourselves about the cultures and events that are close to our friends, family and community members. LGBTQ History Month Although Pride Month is recognized in June, lesbian, gay, bisexual, transgender and questioning/queer (LGBTQ) History Month gets the spotlight … Read more

UNC Health Sponsoring Pride Parade Celebration

September 15, 2022

Pride: Durham, NC 2022 UNC Health is a sponsor of this year’s Pride celebration. On September 24, you can celebrate and support the LGBTQ community. There will be a parade, festival and concert in Durham. The annual event brings family, love, pride and activism to the area.  

“The Best of the Best”: Department of Medicine Boasts a Number of Former Chief Residents

September 13, 2022

The success of a residency program rests on the shoulders of its distinguished chief residents. Chief residents—selected from the top of the class—are role models of leadership and professionalism. They are not only in charge of carrying out administrative duties and managing clinical responsibilities as faculty physicians, but they also serve as teachers, mentors, advocates, … Read more

Drs. Rubin, Styner Publish “The Skeleton in a Physical World”

September 13, 2022

Janet Rubin, MD, is the Sarah Graham Kenan Distinguished Professor of Medicine in the Division of Endocrinology and Metabolism and vice chair for research in the Department of Medicine. Maya Styner, MD is an associate professor of medicine in the Division of Endocrinology and Metabolism.  In the article, Drs. Rubin and Styner consider how the … Read more

Dr. Longobardi’s Research Demonstrates Deletion of Ccr2 in Cartilaginous Tissues Reduces Impact of Post Traumatic Osteoarthritis & Pain

September 12, 2022

Lara Longobardi, PhD, is an associate professor in the the Division of Rheumatology, Allergy and Immunology. The research showed early deletion of Ccr2 in aggrecan-expressing cells reduces the initiation, but not the progression, of post traumatic osteoarthritis and its associated pain. View the article published in Osteoarthritis and Cartilage.

IGHID Investigators Discuss Projects As New Academic Year Begins

September 1, 2022

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings … Read more

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 31, 2022

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.